160 related articles for article (PubMed ID: 2909420)
1. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
[TBL] [Abstract][Full Text] [Related]
2. Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.
Leonhardt U; Seidensticker F; Fussek M; Stöckmann F; Creutzfeldt W
Gut; 1990 Aug; 31(8):934-7. PubMed ID: 2387520
[TBL] [Abstract][Full Text] [Related]
3. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
[TBL] [Abstract][Full Text] [Related]
4. Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis.
Ohshio G; Saluja AK; Leli U; Sengupta A; Steer ML
Gastroenterology; 1989 Mar; 96(3):853-9. PubMed ID: 2464526
[TBL] [Abstract][Full Text] [Related]
5. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
Wisner JR; Renner IG; Grendell JH; Niederau C; Ferrell LD
Pancreas; 1987; 2(2):181-6. PubMed ID: 2442741
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis.
Yang CY; Chang-Chien CS; Liaw YF
Pancreas; 1987; 2(6):698-700. PubMed ID: 3125546
[TBL] [Abstract][Full Text] [Related]
7. Effect of protease inhibitor FUT-175 on acute hemorrhagic pancreatitis in mice.
Suzuki M; Isaji S; Stanten R; Frey CF; Ruebner B
Int J Pancreatol; 1992 Feb; 11(1):59-65. PubMed ID: 1374785
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
[TBL] [Abstract][Full Text] [Related]
9. Effect of FOY-305 (Camostate) on severe acute pancreatitis in two experimental animal models.
Redmond HP; Leahy AL; Keane FB; Tanner WA
Gastroenterology; 1989 Dec; 97(6):1600. PubMed ID: 2583426
[No Abstract] [Full Text] [Related]
10. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
Dabrowski A; Gabryelewicz A
J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
Freise J
Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
[TBL] [Abstract][Full Text] [Related]
12. Elimination of the low-molecular weight proteinase inhibitor camostate (FOY 305) and its degradation products by the rat liver.
Beckh K; Göke B; Müller R; Arnold R
Res Exp Med (Berl); 1987; 187(6):401-6. PubMed ID: 3441682
[TBL] [Abstract][Full Text] [Related]
13. Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis.
Niederau C; Niederau M; Borchard F; Ude K; Lüthen R; Strohmeyer G; Ferrell LD; Grendell JH
Pancreas; 1992; 7(4):486-96. PubMed ID: 1641391
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor.
Niederau C; Crass RA; Silver G; Ferrell LD; Grendell JH
Gastroenterology; 1988 Dec; 95(6):1648-57. PubMed ID: 3141239
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas.
Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG
Digestion; 1987; 37(3):144-8. PubMed ID: 2443410
[TBL] [Abstract][Full Text] [Related]
16. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
Freise J; Melzer P; Schmidt FW; Horbach L
Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.
Niederau C; Liddle RA; Ferrell LD; Grendell JH
J Clin Invest; 1986 Oct; 78(4):1056-63. PubMed ID: 2428840
[TBL] [Abstract][Full Text] [Related]
18. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
Hirano T; Manabe T; Tobe T
J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
Lhoste EF; Roebuck BD; Longnecker DS
Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
[TBL] [Abstract][Full Text] [Related]
20. General and selective inhibition of pancreatic enzyme discharge using a proteinase inhibitor (FOY-305).
Adler G; Rausch U; Weidenbach F; Arnold R; Kern HF
Klin Wochenschr; 1984 May; 62(9):406-11. PubMed ID: 6202931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
